Skip to main content
. 2022 Mar 14;35:10345. doi: 10.3389/ti.2022.10345

TABLE 1.

Donor characteristics according to kidney allograft preservation technique (N = 6,610).

Cold preservation Machine perfusion p-value
N = 5,474 N = 1,136
Sex, N (%) 0.660
 Male 3,388 (61.9) 711 (62.6)
 Female 2,086 (38.1) 425 (37.4)
Age (years), median (IQR) 34 (24–47) 36 (26–49) <0.001
Race/ethnicity, N (%) 0.341
 White 3,569 (62.5) 750 (66.0)
 Black 849 (15.5) 169 (14.9)
 Hispanic 836 (15.3) 183 (16.1)
 Asian/other 220 (4.0) 34 (3.0)
Hypertension, N (%) 1,153 (21.2) 264 (23.5) 0.091
Diabetes, N (%) 228 (4.2) 71 (6.3) 0.002
KDPI category, N (%) 0.003
 <20% 1,933 (36.5) 356 (31.4)
 20–34% 1,022 (18.7) 237 (20.9)
 35–85% 2,235 (40.9) 482 (42.5)
 >85% 210 (3.9) 59 (5.2)
DCD donor, N (%) 224 (4.5) 90 (7.9) <0.001
Kidney CIT (hours), median (IQR) 10.0 (7.7–12.8) 12.8 (9.4–21.7) <0.001
Liver CIT (hours), median (IQR) 6.1 (5.0–7.7) 6.0 (4.7–7.6) 0.074
Split liver, N (%) 81 (1.5) 12 (1.1) 0.270
Distance to donor (miles), median (IQR) 59 (8–158) 52 (8–166) 0.492
Share type, N (%) 0.018
 Local 4,099 (74.9) 858 (75.5)
 Regional 1,241 (22.7) 235 (20.7)
 National 134 (2.5) 43 (3.8)
Cause of death, N (%) 0.002
 Anoxia 1,625 (29.7) 407 (35.8)
 Stroke 1,494 (27.3) 277 (24.4)
 Head trauma 2,188 (40.0) 420 (37.0)
 CNS tumor 35 (0.64) 5 (0.4)
 Other 132 (2.4) 27 (2.4)
BMI (kg/m2), median (IQR) 25.8 (22.8–29.8) 26.4 (23.3–30.1) 0.001
Terminal creatinine (mg/dl), median (IQR) 0.9 (0.7–1.2) 0.9 (0.7–1.2) 0.267
HCV antibody positive, N (%) 399 (7.3) 88 (7.8) 0.599